SDG 3 Newsletter: Infectious Diseases
Published in Social Sciences, Microbiology, and Biomedical Research
What are we learning from the UK's Meningitis B outbreak?
An outbreak of Meningitis B rippled through the UK's student population in March. Have we learnt anything about how the public react to infectious disease outbreaks since Covid? UK readers, learn how to check if you're vaccinated. 
Regional bias in research on land use change, ecosystem restoration and zoonotic disease risk
Research has long shown that land use change can impact zoonotic disease transmission, but there is a regional bias across the literature leaving glaring gaps where research is needed most, in countries with high levels of land use change and high risk of zoonotic disease infection.
SDG3 and Me Video Series: Albert Osterhaus
Virologist and Editor-in-Chief of One Health Outlook, Professor Albert Osterhaus, discusses his research on virus discovery, particularly animal viruses that cross the species barrier to humans. Learn how his work supports intervention strategies such as new vaccines, which are key to achieving SDG 3 target 3.3 by 2030.

Book Q&A: Dengue Virus Evolution: From Emergence to a Global Health Crisis
As climate change has worsened, so has dengue. But there’s hope. In this blog, we hear from Dr Duarte dos Santos and Dr Giovanetti about dengue virus, their book's connection to SDG 3 and the next steps forward.
Advances in infectious disease diagnostics – how can they help us achieve SDG3.3?
Diagnostic tools for infectious diseases have advanced dramatically in recent years. How important are these tools in achieving SDG3.3, and which options should we invest in? Discover more in this blog.

SN BEN, SDG 3 & SDG 10: Ebola
Members of Springer Nature’s Black Employee Network (SN BEN) explore how Ebola virus disease disproportionately affects African communities, and how collective action with charities and public awareness can help destigmatise Ebola and advance good health (SDG 3) and reduced inequalities (SDG 10).
BMC Global and Public Health: Infectious Diseases and SDG 3
As global health is called into focus, don't miss this blog championing some of BMC Global and Public Health's key infectious disease publications.
Nature, BMC & Discover Collections: health policy, digital and personalised medicine
Researchers, don’t miss these open collections. Two blogs from Nature Communications and npj journals showcase collections focusing on health policy and digital medicine. Discover Nano's Collection focuses on the application of nanomedicines in the treatment of infectious diseases. Meanwhile, BMC Infectious Diseases calls for submissions to Collections on personalised medicine, HIV, malaria, and tropical vector‑borne diseases.
Documenting Disruption: Harm Reduction Research on Infectious Disease is Urgently Needed
Global health gains are being undone by aid cuts, conflict and political retreat. Harm Reduction Journal is calling for content to document the impact on infectious disease.

In other news...
A call to action from the Global Think-tank on Steatotic Liver Disease
SLD is no longer an emerging issue. It is an established component of the global metabolic public health threat. The question is not whether solutions exist, but whether they will be implemented at scale. Learn more about the authors' publication in this blog.
European Public Health Week 4-8 May
Want to write a blog about your research? Wish to highlight a public health cause close to your heart? Contact us last-minute to contribute a blog for our campaign, which goes live next week! Email campaign lead Alex Goodridge at alex.goodridge@springernature.com
Get involved!
If you would like to be involved with our SDG 3 initiatives, contact me or Virginia Mercer. Follow me, Alice Coe, on Research Communities to be notified of future SDG 3 newsletters.
With special thanks to this newsletter's 21 contributors: Anthony Armenta, Freyja Austin, Binta Bah, Vivian Bai, Emma Brode, Emma Campbell, Rebecca Chen, Ben Cranfield, India Sapsed-Foster, Louis Gautier, Dr Marta Giovanetti, Sophie Gray, Natasha Hirst, Amy Joint, Abiola Lawal, Dr Jeffrey Lazarus, Virginia Mercer, Dr Claudia Nunes Duarte dos Santos, Prof Albert Osterhaus, Will Shadbolt and Rebecca Shen
Follow the Topic
-
BMC Global and Public Health
An open access, transparent peer review journal publishing outstanding and influential research and opinion of broad interest to all professional communities involved in global and public health research, policy-making, implementation and delivery worldwide.
-
BMC Infectious Diseases
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
-
Nature Communications
An open access, multidisciplinary journal dedicated to publishing high-quality research in all areas of the biological, health, physical, chemical and Earth sciences.
-
Journal of Epidemiology and Global Health
The journal aims to impact global epidemiology and international health with articles focused on innovative scholarship and strategies to advance global health policy.
-
One Health Outlook
This journal is a new open access journal published by BMC in collaboration with the Global One Health Community.
-
Harm Reduction Journal
This journal publishes research and commentary on approaches diminishing the harm of stigmatization, marginalization and criminalization of public health, human rights and social justice issues, as well as rebuking the de facto criminalization of marginalized and stigmatized communities.
-
Nature Health
Nature Health publishes health research across the medical, social and environmental sciences and requires meaningful engagement with research participants and their communities.
-
Communications Health
This is an open access journal from Nature Portfolio publishing high-quality research, reviews and commentary in all population health-related areas of research.
Related Collections
With Collections, you can get published faster and increase your visibility.
Advanced data-driven analytical frameworks to support and improve policy decisions
BMC Global and Public Health is calling for submissions to our Collection on how the integration of advanced data-driven methods in public health policy is rapidly transforming how we understand and respond to global health challenges. This Collection focuses on the application of innovative statistical modelling, machine learning, and geographic information systems (GIS) to inform health policy decisions. By integrating data from surveys and health records with information on social and environmental determinants, researchers can uncover actionable insights that enhance the effectiveness and efficiency of health interventions across diverse populations.
The relevance of these advanced methodologies is underscored by recent advancements in methods for data collection and analysis, which have enabled researchers to create more precise models for predicting disease outbreaks, evaluating health interventions, and addressing health disparities. As public health continues to confront complex issues such as pandemics and non-communicable diseases, the ability to leverage data-driven strategies becomes increasingly vital for crafting evidence-based policies that are responsive to real-world challenges.
Continued research in this area could lead to groundbreaking methodologies that enhance our understanding of health dynamics and improve public health responses. Future advancements may include the development of real-time data analytics for tracking disease spread, enhanced spatial epidemiological models that account for environmental variables, and improved collaboration between data scientists and public health professionals. By further integrating data science with public health, we can pave the way for more effective interventions and ultimately improve health outcomes globally.
We encourage submissions in the following areas, with a particular interest in studies relevant to low- and middle-income countries (LMICs); however, contributions from all settings are welcome, including:
- Applications of Machine Learning in Public Health
- Spatial Epidemiology and Disease Mapping
- Statistical Modeling for Health Policy Decisions
- GIS in Public Health Decision Making
- Evidence-Based Approaches to Infectious and Non-communicable Diseases
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Aug 14, 2026
The Enhanced Games: Human Enhancement, Risk, and Harm Reduction in a Post-Doping Era
Debates about performance-enhancing substances in sport have historically been framed through prohibition, anti-doping enforcement, and ideals of fairness, natural ability, and sport integrity. The proposed Enhanced Games – an international sporting event that explicitly permits the use of performance-enhancing substances – have been presented as a profound rupture in how sport, medicine, and society understand human limits, bodily risk, and enhancement. This collection asks what it means to govern, reduce harm, and protect wellbeing in a world where the use of performance-enhancement substances is increasingly visible, normalised, and commercialised.
The Enhanced Games position themselves as rejecting prohibition, reframing enhancement as positive when transparent and regulated, and describe it as technologically inevitable. In doing so, the Games propose a departure from paternalistic-type interventions in favour of autonomy and science. However, the goals of the Enhanced Games stretch far beyond the sporting arena into the supplement and pharmaceutical industries, sparking concerns regarding competing and conflicting interests. Their scale, visibility, and commercial profile have drawn significant public attention, making questions about governance, enhancement, health, fairness, and harm increasingly urgent to address.
Importantly, this collection does not advocate for or against the Enhanced Games. Instead, it aims to provide a forum for scholarly discussion of the ethical, clinical, regulatory, and social questions raised by this proposal. Given the limited empirical literature currently examining such models of openly permitted enhancement, contributions both supporting and critically challenging this idea are particularly needed. This Collection is explicitly dedicated to examining the Enhanced Games as a social, ethical, public health, and harm reduction phenomenon.
Beyond the existence of human enhancement, the Enhanced Games themselves raise urgent questions:
- Could an openly permitted and regulated model of performance enhancement reduce or mitigate harms associated with the current prohibition of enhancement drugs in sport?
- What are the strongest arguments against such an approach, and how do these concerns compare with the potential benefits claimed by proponents?
- Who bears responsibility for risk in environments where pharmacological enhancement is permitted?
- What does autonomy look like within the Enhanced Games model?
- What constitutes informed consent in high-stakes, financially sponsored performance contexts?
- Can harm reduction meaningfully coexist with elite competition and commercial sport promoted as spectacle?
- Are the vast monetary rewards offered the Enhanced Games for athletes that break ‘world records’ a coercive offer?
- Are there differences between public perceptions of the Games and the realities of athlete participation, and how might both shape decision-making among athletes and spectators?
- Are athletes vulnerable within the Enhanced Games model?
- What lessons might this model offer for broader enhancement practices beyond sport?
The Harm Reduction Journal invites interdisciplinary contributions that critically engage with the Enhanced Games, situating them within wider enhancement cultures, drug use practices, regulatory systems, and harm reduction frameworks. The legitimacy of the Enhanced Games as an alternative model for harm reduction remains an open question. Lived-living experience perspectives on enhancement and risk are specifically encouraged.
This Collection aims to provide the first dedicated harm reduction–focused scholarly examination of the Enhanced Games. The Editors seek to promote evidence-based analysis and discussion of policy, sport governance, and public health responses to emerging enhancement models.
Scope of the Special Issue
We welcome empirical, theoretical, policy, and commentary papers addressing topics including, but not limited to:
1. Enhanced Games–Embedded Research and Case Studies
Empirical papers drawing directly on the Enhanced Games, affiliated teams, athletes, or operational settings, including, where ethically appropriate and critically engaged:
- Biomedical, performance, and health monitoring data from Enhanced Games athletes
- Case studies of elite athletes using enhancement drugs within enhancement-permissive environments
- Governance, safety, and medical oversight models implemented by the Enhanced Games
- Ethical and operational challenges encountered in practice
2. Comparative Studies, Trials, and Harm Analysis
Research examining empirical evidence that may support or challenge the implementation of the Enhanced Games, including quantitative, qualitative, mixed-methods, and trial-based studies that compare:
- Enhanced Games athletes using enhancement drugs vs elite athletes operating under prohibition-based regimes
- Elite athletes using enhancement drugs vs non-athletes using similar substances
- Consumers vs non-consumers in comparable populations (e.g., fitness, strength, or aesthetic domains)
3. Commentary, Policy, and Lived-Living Experience
Analytical and reflective contributions examining:
- Ethical, legal, and public health implications of the Enhanced Games
- Athlete autonomy, consent, coercion, and commercialisation
- Lived and living experience of athletes and others who use enhancement drugs
- Perspectives from clinicians, harm reduction workers, regulators, and policymakers
- Implications for future sport governance, drug policy, and harm reduction frameworks
This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being.
All submissions in this collection undergo the journal’s standard peer review process. Where necessary, Guest Editors will ensure peer-review is provided by those unaffiliated with the Enhanced Games in any way and will ensure diversity is strongly considered with regards to gender, ethnicity, geography and lived/living experience. All manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (APC). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit Harm Reduction Journal's Fees and Funding page, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Dec 16, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in